Investigative Radiology · 1984 · 10 citations · 0 references
MedicineCardiologyCardiac Nuclear MedicineClinical CardiologyNuclear CardiologyCardiac BiomarkersCardiovascular DiseaseCoronary AngiographyCoronary Artery DiseaseIschemic Heart DiseaseMyocardial Perfusion ImagingCardiac Metabolism ImagingCoronary HemodynamicsLactate AccumulationMetabolic Imaging ComparisonMyocardial Energy MetabolismMyocardial MetabolismMyocardial Tracer Uptake AssessmentMyocardial Uptake Quantification
The purpose of this study was to determine the effects of a new nonionic contrast agent (iopamidol) on myocardial metabolism and to compare these effects with those of Renografin-76. Eighteen patients with symptoms of ischemic heart disease undergoing elective left ventriculography and coronary angiography were included in a randomized, double-blind study of iopamidol (n= 8) and Renografin-76. (n= 10). Coronary sinus and arterial blood samples were obtained for free fatty acids, lactate, and oxygen content before and for the 20-minute period following the left ventriculogram. Coronary blood flow was determined by the thermodilution technique. In both groups there was a significant fall in the arterial level of free fatty acids following the left ventriculogram (P < 0.005). In the Renografin-76 group there was a significant fall in myocardial lactate uptake (P < 0.025) at 5 minutes following ventriculography, which persisted and was still significant at the end of the sampling period (P < 0.025). In the iopamidol group there was significant increase in myocardial lactate uptake at 5 minutes after the contrast ventriculogram (P < 0.01) Although the increase in lactate uptake persisted at the 20-minute sampling period, it was no longer statistically significant after 5 minutes. The physiologic response to a fall in arterial free fatty acids is an increase in myocardial lactate extraction. The increase in lactate uptake following the injection of iopamidol follows this physiologic response. Following Renografin-76 ventriculography, there was a decrease in lactate uptake associated with the fall in arterial free fatty acids; this fall in lactate extraction may be related to myocardial ischemia. These metabolic parameters indicate that iopamidol is a less toxic contrast medium for the myocardium than Renografin-76.